A practical reference on lyophilisation: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-04-29 and is reviewed periodically as new material appears.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography, often paired with mass spectrometry using electrospray or MALDI ionisation. Amino acid analysis and peptide mapping by enzymatic digestion provide additional sequence-level confirmation. Purity is commonly reported as an area percentage from a chromatographic trace, and water content can be measured by Karl Fischer titration. Reported masses may differ by tens of daltons between sources because preparations can contain acetate or trifluoroacetate counterions, and such differences are not by themselves evidence of a different peptide.
BPC-157 is normally distributed as a lyophilised powder that ranges from white to off-white in appearance. The peptide dissolves readily in water, normal saline, and common aqueous buffers, and it is poorly soluble in nonpolar solvents such as hexane or vegetable oils. Lyophilised vials take up moisture if left open, which changes the mass of powder in the container and complicates any later weighing. Because the material is handled in small quantities, static and adhesion to glass or plastic can also cause noticeable losses during transfer.
| Property | Value | Notes |
|---|---|---|
| Main study model | Rodents, rats and mice | Underpins most of the published data |
| Common routes in studies | Subcutaneous, intraperitoneal, oral | Varies with the experimental design |
| Common analytical method | Reversed-phase HPLC, LC-MS | Used for identity and purity checks |
| Human evidence base | Small | Few trials reported, with limited findings |
| Regulatory status | Varies by jurisdiction | Not an approved medicine in most places |
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
Most published findings come from rodent experiments using induced injury or surgical models. Human reports remain scarce and are largely observational, which limits how much can be stated with confidence. Questions about absorption, distribution, metabolism, and clearance in people are still open. Dose translation between species is likewise unresolved. Researchers tend to read the animal literature as a starting point rather than a settled account.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Cricket is the most popular sport in Pakistan, followed by football. Field hockey is the national sport. Other sports like squash, polo, and traditional games are also enjoyed. In cricket, Pakistan holds victories in all major ICC tournaments, including the ICC Cricket World Cup, ICC World Twenty20, and ICC Champions Trophy. The Pakistan Super League ranks among the top T20 leagues globally. In football, Pakistan established the Pakistan Football Federation soon after its creation, and it is known for producing FIFA World Cup balls. In field hockey, Pakistan holds four Hockey World Cup wins, eight Asian Games gold medals, and three Olympic gold medals. Squash player Jahangir Khan holds the record for the longest winning streak in professional sport history, winning 555 consecutive matches. Pakistan has hosted various international events, including Cricket and Hockey World Cups and Asian Games.
=== Pharmacokinetics === Abrocitinib is quickly absorbed from the gut and generally reaches highest blood plasma concentrations within one hour. Only 1.0 to 4.4% of the dose are found unmetabolized in the urine. The half-life of abrocitinib is 5 hours and the absorption is not affected by food. A higher dose (400–800 mg) would delay the absorption to 1.5–4 hours. A steady plasma concentration of abrocitinib can be obtained within 48 hours of treatments. The dose is one daily, and abrocitinib is metabolized mainly by cytochrome P450 (CYP450) in liver such as CYP2C9, CYP2C19, CYP3A4 and CYP2B6. The major metabolites of abrocitinib are pyrrolidinone pyrimidine (inactive), 2-hydroxypropyl (active), and 3-hydroxypropyl (active). Dose reduction to half is advisable when abrocitinib is taken with strong inhibitors of CYP2C19. According to phase 1 clinical trials on abrocitinib oral dose of 200 mg, hepatic functions were not altered. However, it is advisable to reduce the dose by half in case of reduced renal function. In serious hepatic impairment and final stages of renal disease, Abrocitinib is contraindicated. Some changes may occur during the abrocitinib treatment such as the reduction in platelet counts after 4 weeks of starting Abrocitinib. However, they will return to normal at the end of the treatment. An increase in LDL, HDL, and total cholesterol levels was also recorded after 4 weeks of Abrocitinib treatment. The increased levels depend on the abrocitinib dose (15% increase in LDL with 200 mg dose versus 10% increase with 100 mg).
Chain Home, or CH for short, was the codename for the ring of coastal early warning radar stations built by the Royal Air Force (RAF) before and during the Second World War to detect and track aircraft. Initially known as RDF, and given the official name Air Ministry Experimental Station Type 1 (AMES Type 1) in 1940, the radar units were also known as Chain Home for most of their life. Chain Home was the first early warning radar network in the world and the first military radar system to reach operational status. Its effect on the war made it one of the most powerful systems of what became known as the "Wizard War". In late 1934, the Tizard Committee asked radio expert Robert Watson-Watt to comment on the repeated claims of radio death rays and reports suggesting Germany had built some sort of radio weapon. His assistant, Arnold Wilkins, demonstrated that a death ray was impossible but suggested radio could be used for long-range detection. In February 1935, a successful demonstration was arranged by placing a receiver near a BBC short wave transmitter and flying an aircraft around the area. Using commercial short wave radio hardware, Watt's team built a prototype pulsed transmitter and, by June 1935, it detected an aircraft that happened to be flying past. Basic development was completed by the end of the year, with detection ranges on the order of 100 mi (160 km). In 1936, attention was focused on a production version, and early 1937 saw the addition of height finding.
In advanced cases, bulging of the cornea can result in a localized rupture of Descemet's membrane, an inner layer of the cornea. Aqueous humor from the eye's anterior chamber seeps into the cornea before Descemet's membrane reseals. The patient experiences pain and a sudden severe clouding of vision, with the cornea taking on a translucent milky-white appearance known as a corneal hydrops. Although disconcerting to the patient, the effect is normally temporary and after a period of six to eight weeks, the cornea usually returns to its former transparency. The recovery can be aided nonsurgically by bandaging with an osmotic saline solution. Although a hydrops usually causes increased scarring of the cornea, occasionally it will benefit a patient by creating a flatter cone, aiding the fitting of contact lenses. Corneal transplantation is not usually indicated during corneal hydrops.
Insulin potentiation therapy (IPT) is an unproven alternative cancer treatment using insulin as an adjunct to low-dose chemotherapy. It was promoted by a paper in the controversial and non-peer reviewed journal Medical Hypotheses. It is not an evidence-based cancer treatment, and the costs of IPT are not covered by health insurance. According to Quackwatch, "Insulin Potentiation Therapy (IPT) is one of several unproven, dangerous treatments that is promoted by a small group of practitioners without trustworthy evidence that it works."
Sources: en.wikipedia.org
The spine ends at the caudal peduncle, the base of the caudal fin, distinguishing this group from those in which the spine extends into the upper lobe of the caudal fin, such as most fish from the Paleozoic (541 to 252 million years ago). The neural arches are elongated to form uroneurals which provide support for this upper lobe. Teleosts tend to be quicker and more flexible than more basal bony fishes. Their skeletal structure has evolved towards greater lightness. While teleost bones are well calcified, they are constructed from a scaffolding of struts, rather than the dense cancellous bones of holostean fish. In addition, the lower jaw of the teleost is reduced to just three bones; the dentary, the angular bone and the articular bone. The genital and urinary tracts end behind the anus in the genital papilla; this is observed to sex teleosts.
==== Early career (1980–1981) ==== After leaving the Army, Marrow wanted to stay away from gang life and violence and instead make a name for himself as a DJ. As a tribute to Iceberg Slim, Marrow adopted the stage name Ice-T. While performing as a DJ at parties, he received more attention for his rapping, which led Ice-T to pursue a career as a rapper. However, he soon returned to a life of crime and robbed jewelry stores with his high school friends. Ice-T's raps later described how he and his friends pretended to be customers to gain access before smashing the display glass with small sledgehammers. Ice-T's friends Al P. and Sean E. Sean went to prison. Al P. was caught in 1982 and sent to prison for robbing a high-end jewelry store in Laguna Niguel for $2.5 million in jewelry. Sean was arrested for possession of not only cannabis, which Sean sold, but also material stolen by Ice-T. Sean took the blame and served two years in prison. Ice-T stated that he owed a debt of gratitude to Sean because his prison time allowed him to pursue a career as a rapper. Concurrently, he wound up in a car accident and was hospitalized as a John Doe because he did not carry any form of identification due to his criminal activities. After being discharged from the hospital, he decided to abandon the criminal lifestyle and pursue a professional career rapping. Two weeks after being released from the hospital, he won an open mic competition judged by Kurtis Blow at the Carolina West nightclub.
=== Alpha crystallins === The α-crystallins, which contributed to the discovery of crystallins as borrowed proteins, have continually supported the theory of gene sharing, and helped delineating the mechanisms used for gene sharing as well. There are two α-crystallin genes (αA and αB), which are about 55% identical in amino acid sequence. Expression studies in non-lens cells showed that the αB-crystallin, other than being a functional lens protein, is a functional small heat shock protein. αB-crystallin is induced by heat and other physiological stresses, and it can protect the cells from elevated temperatures and hypertonic stress. αB-crystallin is also overexpressed in many pathologies, including neurodegenerative diseases, fibroblasts of patients with Werner syndrome showing premature senescence, and growth abnormalities. In addition to being overexpressed under abnormal conditions, αB-crystallin is constitutively expressed in heart, skeletal muscle, kidney, lung and many other tissues. In contrast to αB-crystallin, except for low-level expression in the thymus, spleen and retina, αA-crystallin is highly specialized for expression in the lens and is not stress-inducible. However, like αB-crystallin, it can also function as molecular chaperone and protect against thermal stress.
electron magnetic dipole moment Also electron magnetic moment. The magnetic moment of an electron, caused by the intrinsic properties of its spin and electric charge, equal to approximately −9.284764×10−24 joules per tesla.
Sources: en.wikipedia.org
A simple substance is a substance formed from atoms of one chemical element. The simple substances of the more electronegative atoms tend to share electrons (form covalent bonds) with each other. They form either small molecules (like hydrogen or oxygen) or giant structures stretching indefinitely (like carbon or silicon). The noble gases simply stay as single atoms, as they already have a full shell. Substances composed of discrete molecules or single atoms are held together by weaker attractive forces between the molecules, such as the London dispersion force: as electrons move within the molecules, they create momentary imbalances of electrical charge, which induce similar imbalances on nearby molecules and create synchronized movements of electrons across many neighbouring molecules.
Mental health care navigation helps to guide patients and families through the fragmented, often confusing mental health industries. Care navigators work closely with patients and families through discussion and collaboration to provide information on best therapies as well as referrals to practitioners and facilities specializing in particular forms of emotional improvement. The difference between therapy and care navigation is that the care navigation process provides information and directs patients to therapy rather than providing therapy. Still, care navigators may offer diagnosis and treatment planning. Though many care navigators are also trained therapists and doctors. Care navigation is the link between the patient and the below therapies. A clear recognition that mental health requires medical intervention was demonstrated in a study by Kessler et al. of the prevalence and treatment of mental disorders from 1990 to 2003 in the United States. Despite the prevalence of mental health disorders remaining unchanged during this period, the number of patients seeking treatment for mental disorders increased threefold.
== Awards == 2005 Hoechst Senior Lecturership in Diabetes by Diamond APICON 2009 Professor P.J. Mehta Oration Award by Association of Physicians of India 2011: Received the Professor Sam G.P. Moses Oration from Research Society for the Study of Diabetes (RSSDI) 2013 Vivian Foncseca Scholar Award from the American Diabetes Association for his research on the link between Diabetes and TB. 2014 Professor Sam. G. P. Moses Oration and Gold Medal Oration from Research Society for the Study of Diabetes (RSSDI) 2014 Dr. B Ramamurthy Endowment Lecture Award, Indian Medical Association Branch 2015 Gold Medal Oration by Research Society for the Study of Diabetes (RSSDI) 2015 Medical Council Award by Governor of Tamil Nadu at Tamil Nadu Medical Council, Chennai 2017 Fellowship Award by Research Society for the Study of Diabetes (RSSDI) 2018 Inspiring Diabetologist of India from Anupriya Patel, Minister of State- Health and Family Welfare Govt of India 2018 Excellence in Diabetic Foot Award from the National Diabetic Foot Conclave 2019 Outstanding Investigator Award from the World-India Diabetes Foundation, a US-based organization in 2019. 2022 Second prize at the 18th European Diabetic Foot Study Group (DFSG) meeting in Bratislava, Slovakia for his research paper submitted on “Improving blood flow and saving the legs of people with Diabetes”
Sources: en.wikipedia.org
Animal experiments form the bulk of the published record. Rodent models of tendon, ligament, bone, and gut injury are the most common designs. Controlled human trials are rare, which limits confidence in any clinical claim.
They are best described as working hypotheses. Supporting data come mainly from cell cultures and animal tissue, using markers such as growth factors and inflammatory signals. Confirmatory human studies have not been reported.
Status depends on the country. In some places it is treated as a research chemical available without a prescription, while elsewhere it falls under prescription or controlled rules. It holds no general marketing approval as a therapeutic product.
Lyophilised peptide powders are generally kept frozen or refrigerated, dry, and protected from light. Sealed vials limit moisture uptake and slow hydrolysis. Such guidance comes from general peptide chemistry rather than from stability studies specific to every product.